This is a novel syndrome of growth retardation that presents with progressive growth failure with markedly elevated circulating IGF‐I, IGF‐II, IGFBP‐3, IGFBP‐5, and ALS, but decreased fIGF‐I levels and IGF bioactivity. The gene discussed is IGF1; the disease is amyotrophic lateral sclerosis.